1.18
price down icon2.48%   -0.03
after-market Dopo l'orario di chiusura: 1.20 0.02 +1.69%
loading
Precedente Chiudi:
$1.21
Aprire:
$1.22
Volume 24 ore:
16,880
Relative Volume:
0.74
Capitalizzazione di mercato:
$61.20M
Reddito:
$151.37M
Utile/perdita netta:
$-36.78M
Rapporto P/E:
-1.2341
EPS:
-0.9562
Flusso di cassa netto:
$25.70M
1 W Prestazione:
-16.84%
1M Prestazione:
-18.06%
6M Prestazione:
-42.16%
1 anno Prestazione:
-15.11%
Intervallo 1D:
Value
$1.15
$1.235
Intervallo di 1 settimana:
Value
$1.15
$1.40
Portata 52W:
Value
$0.80
$3.8799

Zenvia Inc Stock (ZENV) Company Profile

Name
Nome
Zenvia Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
1,076
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ZENV's Discussions on Twitter

Zenvia Inc Stock (ZENV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-09-21 Downgrade Itau BBA Outperform → Market Perform
2021-08-23 Iniziato Itau BBA Outperform
2021-08-16 Iniziato Goldman Buy

Zenvia Inc Borsa (ZENV) Ultime notizie

pulisher
Nov 02, 2024

This Zenvia Insider Increased Their Holding By 964% Last Year - Simply Wall St

Nov 02, 2024
pulisher
Oct 29, 2024

Zenvia Inc(ZENV) Price Target Increased by 5.68% to 1.58 - MSN

Oct 29, 2024
pulisher
Oct 26, 2024

Zenvia Inc. (NASDAQ:ZENV) Short Interest Update - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Zenvia Inc. (NASDAQ:ZENV) Q2 2024 Earnings Call Transcript - MSN

Oct 25, 2024
pulisher
Oct 21, 2024

Zenvia CMO Marcelo Wakatsuki steps down, interim named By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

Zenvia Inc. Announces Leadership Change in Marketing - TipRanks

Oct 21, 2024
pulisher
Oct 21, 2024

Zenvia CMO Marcelo Wakatsuki steps down, interim named - Investing.com UK

Oct 21, 2024
pulisher
Oct 17, 2024

Zenvia establishes at-the-market equity programme in Brazil - Latin Lawyer

Oct 17, 2024
pulisher
Oct 16, 2024

Zenvia Customer Cloud hits the market with AI to revolutionize Brand-CX - Martechcube

Oct 16, 2024
pulisher
Oct 16, 2024

Zenvia Customer Cloud hits the market with AI to revolutionize Brand-Customer experiences - StockTitan

Oct 16, 2024
pulisher
Oct 13, 2024

Zenvia Inc. (NASDAQ:ZENV) Short Interest Up 24.6% in September - MarketBeat

Oct 13, 2024
pulisher
Sep 25, 2024

Zenvia Inc. (NASDAQ:ZENV) Short Interest Down 59.9% in September - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Invests $3.84 Million in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Sep 25, 2024
pulisher
Sep 18, 2024

Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Canada

Sep 18, 2024
pulisher
Sep 18, 2024

Is this affordable and accessible eyewear brand worth the hype? - Reviewed

Sep 18, 2024
pulisher
Sep 18, 2024

Wedbush lifts Zentalis Pharmaceuticals Inc [ZNTL] price estimate. Who else is bullish? - The DBT News

Sep 18, 2024
pulisher
Sep 18, 2024

Trading Day Review: Zevra Therapeutics Inc (ZVRA) Loses Momentum, Closing at 7.53 - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Adversity is less terrifying than hope: Zentalis Pharmaceuticals Inc (ZNTL) - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

You might want to take a look at Zevra Therapeutics Inc (ZVRA) now - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Potential Price Increase for Zentalis Pharmaceuticals Inc (ZNTL) After Recent Insider Activity - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

Daily Market Movement: Zentalis Pharmaceuticals Inc (ZNTL) Sees a 11.41 Increase, Closing at 4.10 - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Zenith UK appoints Sannah Rogers chief executive - CampaignLive

Sep 18, 2024
pulisher
Sep 18, 2024

Zendaya's baby pics that show she's always been that girl - Hindustan Times

Sep 18, 2024
pulisher
Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor - Pharmaceutical Technology

Sep 17, 2024
pulisher
Sep 17, 2024

Zevra Therapeutics Inc (ZVRA)’s stock decline to 7.78 per share - US Post News

Sep 17, 2024
pulisher
Sep 17, 2024

Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies - Zacks Investment Research

Sep 17, 2024
pulisher
Sep 17, 2024

Zeneara Reviews"HYPE-LEGIT" HAPPY Customer or Controversy? - openPR

Sep 17, 2024
pulisher
Sep 17, 2024

IPO Radar: Applied Nutrition, Zenas BioPharma, BingEx - The Armchair Trader

Sep 17, 2024
pulisher
Sep 17, 2024

Zenith Bank Rises Slightly after ‘Fund’ Amass Huge Shares - MarketForces Africa

Sep 17, 2024
pulisher
Sep 16, 2024

Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Understanding the Risks of Investing in Zevra Therapeutics Inc (ZVRA) - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Pharmaceuticals Inc’s Banking’s 100-Day Moving Average at 6.58: Will the Stock Break Through? - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis clinical hold resolution came ‘no strings attached,’ says Oppenheimer - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Pharma gains as FDA lifts partial clinical hold on cancer drug studies - XM

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies - MarketWatch

Sep 16, 2024
pulisher
Sep 16, 2024

Zentalis Pharmaceuticals Advances with FDA Approval and Upcoming Data - TipRanks

Sep 16, 2024
pulisher
Sep 15, 2024

Zenas Biopharma IPO raises $225 mln in US IPO market - Eyes On News

Sep 15, 2024
pulisher
Sep 13, 2024

Zenas BioPharma shares rise nearly 8% in market debut - XM

Sep 13, 2024
pulisher
Sep 13, 2024

Zenas BioPharma raises $225 mln in US IPO - Reuters

Sep 13, 2024
pulisher
Sep 12, 2024

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering - GlobeNewswire

Sep 12, 2024
pulisher
Sep 10, 2024

Zenvia Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Sep 10, 2024
pulisher
Sep 09, 2024

Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion By Investing.com - Investing.com Canada

Sep 09, 2024
pulisher
Sep 09, 2024

Earnings call: Zenvia reports robust Q2 2024 growth, plans expansion - Investing.com India

Sep 09, 2024
pulisher
Sep 07, 2024

Zenvia Inc. Complies with SEC’s September Filing - TipRanks

Sep 07, 2024
pulisher
Sep 07, 2024

Zenvia Inc. Reports Mid-Year Financial Performance - TipRanks

Sep 07, 2024
pulisher
Sep 07, 2024

Zenvia Inc. Soars with Robust Q2 2024 Earnings - TipRanks

Sep 07, 2024

Zenvia Inc Azioni (ZENV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$241.25
price up icon 0.05%
$291.21
price up icon 0.65%
$79.57
price up icon 1.44%
$366.29
price up icon 1.43%
software_application ADP
$291.18
price up icon 0.46%
$74.15
price up icon 1.23%
Capitalizzazione:     |  Volume (24 ore):